INSM1 Antikörper (N-Term)
Kurzübersicht für INSM1 Antikörper (N-Term) (ABIN499952)
Target
Alle INSM1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- This antibody reacts to IA-1.
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- IA-1 antibody was raised against a 19 amino acid peptide from near the amino terminus of human IA-1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA. Western Blot: 1 - 2 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C.
-
-
- INSM1 (Insulinoma-Associated 1 (INSM1))
-
Andere Bezeichnung
- INSM1 / IA1
-
Hintergrund
- IA-1, also known as INSM1, is an essential five zinc-finger transcription factor that while initially identified from an insulinoma cDNA library, is expressed in the developing nervous system. Specifically, IA-1 is expressed as early as E9.5 in mice in the fore-, mid- and hindbrain, spinal cord, retina, and olfactory bulb. It is thought that IA-1 functions as a transcriptional repressor, and is a part of several signaling pathways including those of Notch and sonic hedgehog in addition to that of Ngn3 during pancreatic endocrine cell differentiation. IA-1 is also expressed in multiple tumors, including the majority of neuroendocrine tumors tested so far as well as nearly 100 % of all small cell lung carcinomas, indicating that IA-1 may be an important target in cancer therapy.Synonyms: Insulinoma-associated protein 1, Zinc finger protein IA-1
-
Gen-ID
- 3642
-
NCBI Accession
- NP_002187
-
UniProt
- Q01101
Target
-